Log in

Beta Drugs

BETA· NSE· Healthcare
₹1,838.50
−₹32.50 (−1.74%) · 1Das of 12 Nov 2026, 21:13 IST

Beta Drugs (BETA) last traded at ₹1,838.50 on NSE as of 12 Nov 2026, 21:13 IST, down 1.74% (−₹32.50) on the day. The stock is 34.5% below its 52-week high of ₹2,807.90 and 85.7% above its 52-week low of ₹990.10. Market cap ₹2,045 crore, trailing P/E 49.3×, P/B 8.4×, EPS ₹40.92. Sector: Healthcare.

Day range₹1,806.10 – ₹1,891.80
52-week range₹990.10 – ₹2,807.90
Volume15,8400.22× the 20-day average
Market cap₹2,045 crore
P/E · P/B49.3× · 8.4×trailing
EPS₹40.92
Returns1W−0.12%1M−0.31%3M−28.46%6M+33.22%YTD+18.62%1Y+9.66%3Y+66.31%5Y+249.39%

Fundamentals

Revenue growth· latest year+6.20%
Net margin10.8%
ROE / ROA— / 8.4%
Debt-to-equity0.6×
P/E · P/B· trailing49.3× · 8.4×
EPS₹40.92
Revenue / net income₹385 crore / ₹41 crore
Last reported year ends 31 Mar 2026

Technicals

RSI (14)47.4
20-day average· 0.3% above₹1,832.11
50-day average· 6.5% below₹1,967.05
200-day average· 6.1% above₹1,732.82
ATR (14)· 6.09% of price₹112.00
20-session change+8.18%
Volatility· 30 sessions, annualised74.1%
From completed sessions; the RSI alone steps with the live price.

Sector today

Healthcare
Move today+0.03%
Breadth53% of stocks up
RotationImproving
Against the NIFTY 50 · breadth is the share of the sector's stocks up today

Latest news

All BETA news ↗
  1. Beta Drugs Standalone September 2026 Net Sales at Rs 58.01 crore, up 6.48% Y-o-Y
    Moneycontrol ↗ · 12 Nov 2026, 14:33 IST · Positive
  2. Beta Drugs Consolidated September 2026 Net Sales at Rs 137.49 crore, up 32.99% Y-o-Y
    Moneycontrol ↗ · 6 Nov 2026, 12:22 IST · Positive

Upcoming events

Event calendar ↗

No upcoming company event is listed for Beta Drugs.

Frequently asked

What is the Beta Drugs share price today?

Beta Drugs (BETA) last traded at ₹1,838.50 on NSE as of 12 Nov 2026, 21:13 IST, down 1.74% (−₹32.50) on the day.

What is the 52-week high and low of BETA?

The 52-week range of Beta Drugs is ₹990.10 to ₹2,807.90; the last price is 34.5% below the high.

What is the market capitalisation of Beta Drugs?

₹2,045 crore at the last price (NSE's issued shares × price).

What is the P/E ratio of Beta Drugs?

Trailing P/E 49.3× on EPS ₹40.92, from the annual statement for the year ended 31 Mar 2026.

Which sector is Beta Drugs in, and how is the sector doing today?

Healthcare. The sector is up 0.03% today, with 53% of its stocks up (Improving against the NIFTY 50).

What is the next scheduled event for Beta Drugs?

No upcoming company event is listed for Beta Drugs.

Data as of 12 Nov 2026, 21:13 IST · Research, not investment advice.